Farther Finance Advisors’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$280K Buy
22,818
+20,597
+927% +$215K ﹤0.01% 2037
2026
Q2
$14.7K Buy
2,221
+2,000
+905% +$10K ﹤0.01% 4176
2026
Q1
$1.1K Sell
221
-26
-11% -$168 ﹤0.01% 5084
2025
Q4
$2.02K Buy
247
+100
+68% +$644 ﹤0.01% 4686
2025
Q3
$866 Buy
147
+121
+465% +$858 ﹤0.01% 4410
2025
Q2
$218 Sell
26
-18
-41% -$131 ﹤0.01% 4190
2025
Q1
$260 Buy
44
+14
+47% +$121 ﹤0.01% 3903
2024
Q4
$265 Buy
+30
New +$305 ﹤0.01% 3586

Other funds holding HELP

Farther Finance Advisors's HELP Position: Q3 2026 in Review

Farther Finance Advisors increased its Helus Pharma Inc. Common Stock (HELP) stake by 927% in Q3 2026, buying an estimated $215K and bringing the position to 22,818 shares worth $280K. The position accounts for ﹤0.01% of the portfolio, ranked #2037.

Farther Finance Advisors first reported a position in HELP in Q4 2024 and has held it in 8 quarters since. 2 funds tracked by Wall St. Rank hold HELP as of Q3 2026.

  • Farther Finance Advisors held 22,818 shares of Helus Pharma Inc. Common Stock worth $280K as of Q3 2026.
  • Farther Finance Advisors bought 20,597 Helus Pharma Inc. Common Stock shares in Q3 2026, an estimated $215K.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2037 holding.
  • Farther Finance Advisors first reported a position in Helus Pharma Inc. Common Stock in Q4 2024 and has held it in 8 quarters since.
  • 2 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.